Le Lézard
Classified in: Health
Subject: AWD

Capital Rx's Customer Care Team Wins 5 Stevie® Awards for Customer Service


NEW YORK, April 17, 2024 /PRNewswire/ -- Capital Rx, the full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA) advancing our nation's healthcare infrastructure to improve drug price visibility and patient outcomes, won five 2024 Stevie® Awards in the Sales & Customer Service category, including one Gold award for Achievement in Customer Experience and two Silver awards for Customer Service Department of the Year ? Healthcare, Pharmaceuticals, and Related Industries and Best Use of Technology in Customer Service - Other Service Industries.

Capital Rx's approach to member service yields five 2024 Stevie® Awards for the department and leadership team members.

Lisa Ellerhorst (Senior Director, Customer Care) and Gismell Abud (Senior Director, Customer Care Support & QA) also took home two Silver awards for Contact Center Leader of the Year and Customer Service Training Professional of the Year, respectively.

Capital Rx continues to strive for excellence in the healthcare industry with respect to customer care, boasting five straight years of a Client NPS over 90 and a Member NPS exceeding 80 since March of 2023.

"I could not be prouder of our team, their tireless effort, and the results they deliver daily. They are on the frontlines every day, talking with members, working with prescribers and pharmacies, and ensuring that every patient receives the highest level of care possible," said Capital Rx Co-Founder & CEO, AJ Loiacono. "These awards are a testament to the team's dedication to delivering an exceptional service experience and prove that leveraging cutting-edge technology like JUDI® raises the bar for the standard of care in our industry."

More than 2,300 nominations from organizations of all sizes and in virtually every industry, in 44 nations and territories, were considered in this year's competition. Winners were determined by the average scores of more than 200 professionals worldwide on seven specialized judging committees.

"We aim to provide patients with high-quality customer care and help our clients make informed decisions about how to manage their pharmacy benefit programs," said Will Tafoya, Senior Vice President, Customer Care. "It brings me great joy to see Lisa and Gismell recognized for their numerous contributions to our department's success. I'm thankful to the Stevie Awards and humbled to lead such an amazing team as we redefine the expectations for member service in the PBM industry."

"The high scores given the winning nominations in this year's competition are evidence of the high levels of achievement portrayed in them," said Stevie Awards president Maggie Miller. "We join with the judges and all members of the Stevie Awards community in congratulating and celebrating the winners for their accomplishments."

Details about the Stevie Awards for Sales & Customer Service and the list of Stevie winners in all categories are available at www.StevieAwards.com/Sales.

About The Stevie® Awards
Stevie Awards are conferred in nine programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Sales & Customer Service, the new Stevie Awards for Technology Excellence, and the Stevie Awards for Women in Business. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. More than 1,000 professionals around the world participate in the Stevie Awards judging process each year. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.

About Capital Rx
Capital Rx is a full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA), advancing our nation's electronic healthcare infrastructure to improve drug price visibility and patient outcomes. As a Certified B Corptm, Capital Rx is executing its mission through the deployment of JUDI®, the company's cloud-native enterprise health platform, and a Single-Ledger Modeltm, which increases visibility and reduces variability in drug prices. JUDI connects every aspect of the pharmacy ecosystem in one efficient, scalable platform, servicing millions of members for Medicare, Medicaid, and commercial plans. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare. To learn more, visit capital-rx.com.

Media Contacts
Justin Venneri, Director of Communications
Michael Passanante, SVP, Marketing & Communications
[email protected]

SOURCE Capital Rx


These press releases may also interest you

at 06:05
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer's disease (AD) and other neurodegenerative disorders, today announced the dosing...

at 06:05
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) today announced that the FDA has approved a label update for LUPKYNIS. The updated label no longer includes language indicating that the safety and efficacy of LUPKYNIS has not been established...

at 06:05
Generate:Biomedicines today announces two key appointments, welcoming Kimberly (Kym) White as the new Chief Corporate Affairs Officer and announcing the promotion of Lisa Wyman to Chief Technical Operations Officer. These appointments not only...

at 06:04
Photocure ASA today announces the publication of the Annual Report and integrated ESG report for 2023. The Board of Directors of Photocure ASA has approved the annual accounts for 2023. The financial statements and annual report for the financial...

at 06:00
AVRICORE HEALTH INC. (the "Company" or "AVCR") is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross profit increased by 163% to...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the...



News published on and distributed by: